Literature DB >> 2445093

Tissue polypeptide antigen (TPA), some cytokeratins and epithelial membrane antigen (EMA) in normal, inflamed and malignant urothelium.

B E Carbin1, V P Collins, P Ekman.   

Abstract

The distribution of tissue polypeptide antigen (TPA), epithelial membrane antigen (EMA) and various cytokeratins was studied with immunohistochemical techniques in malignant, normal and inflamed urothelium. TPA and cytokeratins 8, 18 and 19 were similarly distributed and there was no difference between benign and malignant conditions. All keratins were most abundant in the outer cell layers of the urothelium. EMA was present primarily in the so called umbrella cells. Increased levels of TPA in urine and serum are found in patients with urothelial carcinoma. TPA is reported to be related to the cytoskeletal keratins and its presence definitely does not imply malignant transformation as we have demonstrated it in both benign and malignant urothelium. The increased levels of TPA in urine and serum are probably due to a more rapid turnover and autolysis of cells and may parallel a more aggressive tumor behaviour.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445093     DOI: 10.1007/bf00262097

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  11 in total

1.  Antigenicity of pooled human malignant and normal tissues by cyto-immunological technique; presence of an insoluble, heat-labile tumor antigen.

Authors:  B BJORKLUND; V BJORKLUND
Journal:  Int Arch Allergy Appl Immunol       Date:  1957

2.  Antibody to prekeratin. Decoration of tonofilament like arrays in various cells of epithelial character.

Authors:  W W Franke; K Weber; M Osborn; E Schmid; C Freudenstein
Journal:  Exp Cell Res       Date:  1978-10-15       Impact factor: 3.905

3.  A, B, H antigens in transitional cell tumors of the urinary bladder: correlation with the clinical course.

Authors:  C Limas; P Lange; E E Fraley; R L Vessella
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

4.  A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms.

Authors:  C J Menendez-Botet; H F Oettgen; C M Pinsky; M K Schwartz
Journal:  Clin Chem       Date:  1978-06       Impact factor: 8.327

5.  Histological grading of transitional cell tumours of the bladder. Value of histological grading (WHO) in prognosis.

Authors:  Y Collan; J Mäkinen; A Heikkinen
Journal:  Eur Urol       Date:  1979       Impact factor: 20.096

6.  Significance of plasma tissue polypeptide antigen determination for diagnosis and follow-up of urothelial bladder cancer.

Authors:  H D Adolphs; P Oehr
Journal:  Urol Res       Date:  1984

7.  Tissue polypeptide antigen (TPA) as a prognostic aid in human prostatic carcinoma.

Authors:  A Lewenhaupt; P Ekman; P Eneroth; B Nilsson; L Nordström
Journal:  Prostate       Date:  1985       Impact factor: 4.104

Review 8.  Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: an overview.

Authors:  F C Ramaekers; J J Puts; O Moesker; A Kant; A Huysmans; D Haag; P H Jap; C J Herman; G P Vooijs
Journal:  Histochem J       Date:  1983-07

9.  DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours.

Authors:  H Gustafson; B Tribukait; P L Esposti
Journal:  Scand J Urol Nephrol       Date:  1982

10.  Tissue polypeptide antigen (TPA) is related to the non-epidermal keratins 8, 18 and 19 typical of simple and non-squamous epithelia: re-evaluation of a human tumor marker.

Authors:  K Weber; M Osborn; R Moll; B Wiklund; B Lüning
Journal:  EMBO J       Date:  1984-11       Impact factor: 11.598

View more
  5 in total

1.  Urine-TPA (tissue polypeptide antigen), flow cytometry and cytology as markers for tumor invasiveness in urinary bladder carcinoma.

Authors:  B E Carbin; P Ekman; P Eneroth; B Nilsson
Journal:  Urol Res       Date:  1989

2.  The changing scenario in diagnosing prostate cancer.

Authors:  D Anitha; T Venkatesh
Journal:  Indian J Clin Biochem       Date:  2000-07

3.  Patterns of cytokeratin expression by neoplastic and non-neoplastic epithelium.

Authors:  G Mortimer; D N Jones; H Assaf; T al-Ahmadi
Journal:  Ir J Med Sci       Date:  1993-03       Impact factor: 1.568

4.  The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer.

Authors:  F Desgrandchamps; M Teren; L Dal Cortivo; J P Marolleau; P Bertheau; J M Villette; A Cortesse; P Teillac; A Le Duc; F C Hamdy
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

Review 5.  Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?

Authors:  Nada Humayun-Zakaria; Douglas G Ward; Roland Arnold; Richard T Bryan
Journal:  Transl Androl Urol       Date:  2021-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.